MiniMed Group, Inc. (MMED)
MiniMed Group will go public soon, but the exact IPO date is still unknown.
Stock Price: Pending
IPO price not available yet

Company Description

MiniMed Group is a scaled global medical technology company that develops, manufactures, and markets a comprehensive suite of solutions for the management of diabetes.

Since our founding more than 40 years ago, we have pioneered groundbreaking innovation and served the needs of our customers across the globe in service of our mission to make every day a better day for people with diabetes.

We address this market by offering various diabetes technologies, including insulin delivery devices (primarily insulin pumps and pens), continuous glucose monitors, other consumables, supplies, and related software and services.

MiniMed Group, Inc.
CountryUnited States
Founded1983
IndustryMedical Instruments & Supplies
SectorHealthcare
Employees8,000
CEOQue Dallara

Contact Details

Address:
18000 Devonshire St.
Northridge, CA 91325
United States
Phone(763) 514-4000
Websitemedtronicdiabetes.com

Stock Details

Ticker SymbolMMED
ExchangeNASDAQ
Fiscal YearMay - April
Reporting CurrencyUSD
CIK Code2062583
Employer ID33-3985981
SIC Code3841

Key Executives

NamePosition
Que DallaraChief Executive Officer and Director Nominee
Chad SpoonerExecutive Vice President & Chief Financial Officer
Ali DianatyExecutive Vice President, Chief Product & Technology Officer
Courtney Nelson WillsSenior Vice President, General Counsel
Gillian ChandrasenaSenior Vice President, Chief Human Resources Officer

Latest SEC Filings

DateTypeTitle
Dec 19, 2025S-1General form for registration of securities under the Securities Act of 1933
Oct 28, 2025DRS/A[Amend] [Cover] Draft Registration Statement
Aug 27, 2025DRS/A[Amend] [Cover] Draft Registration Statement
May 30, 2025DRS[Cover] Draft Registration Statement